Recombine Genetics
Stage
AcquiredTotal Raised
$4.3MInvestors Count
7Deal Terms
2Portfolio Exits
2Funding, Valuation & Revenue
3 Fundings
Recombine Genetics has raised $4.3M over 3 rounds.
Recombine Genetics's latest funding round was a Acquired for on May 25, 2016.
Recombine Genetics's latest post-money valuation is from May 2016.
Sign up for a free demo to see Recombine Genetics's valuations in May 2016 and more.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
5/25/2016 | Acquired | 1 | ||||
10/16/2015 | Debt | |||||
3/4/2014 | Series A |
Date | 5/25/2016 | 10/16/2015 | 3/4/2014 |
|---|---|---|---|
Round | Acquired | Debt | Series A |
Amount | |||
Investors | |||
Valuation | |||
Revenue | |||
Sources | 1 |
Recombine Genetics Deal Terms
2 Deal Terms
Recombine Genetics's deal structure is available for 2 funding rounds, including their Acquired from May 25, 2016.
Round | Acquired | Series A |
|---|---|---|
Funding Date | ||
Pre-Money Valuation | ||
Post-Money Valuation | ||
Amount Raised | ||
Shares Authorized | ||
Issuance Price | ||
Dividend Rate | ||
Liquidation Preferences | ||
Liquidation Price | ||
Participation | ||
Conversion Price | ||
Anti Dilution | ||
General Voting | ||
Board Voting | ||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Acquired | |||||||||||||||
Series A |
Recombine Genetics Investors
7 Investors
Recombine Genetics has 7 investors. CooperCompanies invested in Recombine Genetics's Acquired funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
5/25/2016 | 5/25/2016 | 1 Acquired | Corporation | California | ||
Venture Capital | New York | |||||
Venture Capital | New York | |||||
Angel Investor (Individual) | New York | |||||
Angel Investor (Individual) | New York |
First funding | 5/25/2016 | ||||
|---|---|---|---|---|---|
Last Funding | 5/25/2016 | ||||
Investor | |||||
Rounds | 1 Acquired | ||||
Board Seats | |||||
Type | Corporation | Venture Capital | Venture Capital | Angel Investor (Individual) | Angel Investor (Individual) |
Location | California | New York | New York | New York | New York |
Recombine Genetics Portfolio Exits
2 Portfolio Exits
Recombine Genetics has 2 portfolio exits. Their latest portfolio exit was Phosphorus on June 07, 2022.
Loading...